Overview of Delivery of CRISPR/Cas Systems, Its Types and Role in Genome Editing and Immunotherapy
Department of Biochemistry, Government College Women University Faisalabad, Pakistan.
Biography:
Sadia Aslam Chief Scientific Officer (CSO) of GlobalAcorn Ltd, an innovative cancer nanomedicine company that addresses major unmet needs in cancer management. She began chemistry education at the University of Bristol (UK) from where graduated in 1984 with a BSc degree
Subjects of specialization: Cas9-sgRNA, Immunotherapy, CAR-T cells